Principal drug of concern

The following data visualisation shows:

  • Closed treatment episodes for clients who received treatment for their own drug use by PHN of client and principal drug of concern, 2014–15 to 2018–19.
  • Closed treatment episodes for clients who received treatment for their own drug use by PHN of client and main treatment type, 2018–19.
  • Closed treatment episodes for clients who received treatment for their own drug use by PHN of client and source of referral, 2018–19.

In 2018–19, 207,831 closed episodes were provided nationally to clients for their own drug use. Alcohol has remained the most common principal drug of concern between 2014–15 and 2018–19, declining slightly from 38% of treatment episodes to 36%. Amphetamines was the second most common principal drug of concern in 2018–19 (28%), followed by cannabis (20%) and heroin (5.2%). The most common main treatment type in 2018–19 was counselling (38% of episodes), followed by assessment only (19%). Over 1 in 3 treatment episodes (38%) reported self/family as the source of referral, while 30% listed a health service.

Visualisation not available for printing